Objective: To explore the non-laboratory factors affecting fibrinogen (Fib) levels, coagulation factor Ⅷ (FⅧ) activity, and the quality inspection pass rate of fresh frozen plasma (FFP), so as to provide scientific guidance for its preparation, storage, clinical transfusion, and quality inspection. Methods: 1) Twenty bags of B-type Rh(D) positive fresh frozen plasma were randomly selected, and FⅧ activity and Fib levels were determined at different storage times. The data were analyzed using the paired t-test, one-way repeated-measures ANOVA, and the Bonferroni post-hoc test. 2) The detection data of FⅧ activity in fresh frozen plasma from January 2022 to September 2025 were retrospectively analyzed using Welch's ANOVA, multiple comparison tests, chi-square test, rank-sum test, Fisher's exact test and other statistical methods. Results: 1) There were statistically significant differences in FⅧ activity at different storage times (P<0.05), while no significant difference was found in Fib levels (P>0.05). FⅧ activity gradually decreased from 0 h to 48 h and remained stable from 48 h to 120 h. 2) There was no statistically significant difference in FⅧ activity between different genders (P>0.05). In contrast, significant differences were observed across age groups (P<0.05), with FⅧ activity rising markedly in individuals aged over 40. Significant differences in FⅧ activity were also identified among different blood groups (P<0.05), with type O showing the lowest activity and type AB the highest. No significant difference in the pass rate of FFP was found between genders (P>0.05). No statistically significant difference in pass rates was observed across different age groups when stratified by blood type (P>0.05), whereas significant differences in pass rates among different blood types were identified when stratified by age (P<0.05). These differences were found in the 29-39 years and 40-50 years age groups. Conclusion: 1) FⅧ activity in FFP declines rapidly within 48 hours and should be transfused as early as possible. From 48 to 120 hours, FⅧ activity tends to stabilize and remains above 50%, still meeting the requirements for hemostasis. 2) Blood type and age are influencing factors of FⅧ activity in FFP, with the activity ranked as type AB>type B>type A>type O, blood donors aged over 40 show higher FⅧ activity. Gender is not a factor affecting FⅧ activity, although females have higher levels than males. The correlation between blood group and the quality-inspection pass rate of FFP is affected by age stratification. Differences among blood groups and age groups should be considered during the quality control of blood products.

Objective:To evaluate the safety and effectiveness of fuzuloparib for the treatment of ovarian epithelial cancer patients in the real world setting.Methods:A retrospective analysis was conducted on the baseline data of 4 620 ovarian cancer patients who had received fuzuloparib monotherapy or combination therapy. Another 224 ovarian cancer patients who were willing to receive fuzuloparib monotherapy or combination therapy were prospectively enrolled, and their baseline characteristics, drug effectiveness, and safety data were analyzed.Results:(1) Among the 4 620 patients in the retrospective cohort, the median age of patients was 60 years; tumor types: 89.8% (4 149/4 620) had ovarian cancer. Among patients with clearly documented information, the vast majority had a histological type of serous carcinoma (82.9%, 3 770/4 546) and International Federation of Gynecology and Obstetrics (FIGO) staging of Ⅲ-Ⅳ (90.9%, 1 537/1 691). (2) Among the 224 patients in the prospective cohort, the median age of patients was 57 years; tumor types: 83.9% (188/224) had ovarian cancer. Among patients with clearly documented records, the predominant pathologic type was serous carcinoma (91.9%, 193/210), and FIGO stage was Ⅲ-Ⅳ in 79.9% (139/174). (3) Among the 224 prospective patients: 84 patients received first-line fluzoparib maintenance therapy, 92 patients received fluzoparib maintenance therapy after platinum-sensitive recurrence, 23 patients received direct fluzoparib treatment after platinum-sensitive recurrence, 19 patients received direct fluzoparib treatment after platinum-resistant recurrence. The median follow-up durations were 8.5, 8.7, 7.9, and 6.7 months, respectively. The median durations of fluzoparib treatment were 6.7, 4.8, 3.1, and 1.9 months, respectively. The median progression-free survival (PFS) times were not reached during follow-up, 12.6 months, not reached during follow-up, and 4.8 months, respectively. The 1-year PFS rates were 84.1%, 55.0%, 69.8%, and 45.5%, respectively. The remaining 6 patients received other fluzoparib regimens. (4) Among the 224 patients in the prospective dataset, 205 had safety data recorded. Of these, 127 patients (62.0%, 127/205) experienced treatment-related adverse events, with common events including anemia (24.4%, 50/205), thrombocytopenia (21.0%, 43/205), and leukopenia (19.5%, 40/205). Among the 205 patients, 43 (21.0%, 43/205) experienced grade 3 or higher treatment-related adverse events, with common events including anemia (8.3%, 17/205) and thrombocytopenia (8.3%, 17/205).Conclusions:The effectiveness of fuzuloparib in clinical application is generally consistent with other drugs in the same class, with good safety. This study provids new clinical evidence for the treatment of ovarian cancer with fuzuloparib.

OBJECTIVE To explore the effect of oral cleaning with traditional Chinese medicine preparations on de-colonization of oropharyngeal bacteria and hospital-acquired pneumonia(HAP)in elderly patients undergoing non-inva-sive mechanical ventilation.METHODS A total of 520 elderly patients who were treated with non-invasive mechani-cal ventilation in Enze Hospital of Enze Medical Center(Group)from Jan.2022 to Dec.2024 were recruited as the research subjects and were randomly divided into the normal saline group and the traditional Chinese medicine(TCM)preparation group,with 260 cases in each group.The two groups were respectively treated with normal saline and TCM preparations for oral cleaning,twice a day in the morning and evening.The dental plaque index score,isolation rate of oropharyngeal pathogens,incidence of HAP and isolation rates of pathogens causing HAP were observed and compared between the two groups.RESULTS There were no significant differences in the dental plaque index score and the isolation rate of oropharyngeal pathogens between the two groups of patients before the first cleaning.However,the dental plaque index score and the isolation rate of oropharyngeal pathogens were low-er in the TCM preparation group than in the normal saline group after the first cleaning and the continuous clean-ing for 5 days(P＜0.05).The incidence of HAP of the TCM preparation group(3.63％)was lower than that of the normal saline group(8.91％)(x2=5.872,P=0.015).The isolation rate of gram-negative bacteria from lower respiratory tract secretions of the patients with HAP was lower in the TCM preparation group than in the normal saline group(P＜0.05);there were no significant differences in the isolation rates of gram-positive bacteria and fungi between the two groups.CONCLUSION As compared with the normal saline for routine oral cleaning of the elderly patients undergoing non-invasive mechanical ventilation,the TCM preparations may facilitate the decoloni-zation of oropharyngeal bacteria and remarkably reduce the incidence of HAP,which may provide a new idea for decolonization of oropharyngeal bacteria and reduction of incidence of HAP.

Objective:To evaluate the safety and effectiveness of fuzuloparib for the treatment of ovarian epithelial cancer patients in the real world setting.Methods:A retrospective analysis was conducted on the baseline data of 4 620 ovarian cancer patients who had received fuzuloparib monotherapy or combination therapy. Another 224 ovarian cancer patients who were willing to receive fuzuloparib monotherapy or combination therapy were prospectively enrolled, and their baseline characteristics, drug effectiveness, and safety data were analyzed.Results:(1) Among the 4 620 patients in the retrospective cohort, the median age of patients was 60 years; tumor types: 89.8% (4 149/4 620) had ovarian cancer. Among patients with clearly documented information, the vast majority had a histological type of serous carcinoma (82.9%, 3 770/4 546) and International Federation of Gynecology and Obstetrics (FIGO) staging of Ⅲ-Ⅳ (90.9%, 1 537/1 691). (2) Among the 224 patients in the prospective cohort, the median age of patients was 57 years; tumor types: 83.9% (188/224) had ovarian cancer. Among patients with clearly documented records, the predominant pathologic type was serous carcinoma (91.9%, 193/210), and FIGO stage was Ⅲ-Ⅳ in 79.9% (139/174). (3) Among the 224 prospective patients: 84 patients received first-line fluzoparib maintenance therapy, 92 patients received fluzoparib maintenance therapy after platinum-sensitive recurrence, 23 patients received direct fluzoparib treatment after platinum-sensitive recurrence, 19 patients received direct fluzoparib treatment after platinum-resistant recurrence. The median follow-up durations were 8.5, 8.7, 7.9, and 6.7 months, respectively. The median durations of fluzoparib treatment were 6.7, 4.8, 3.1, and 1.9 months, respectively. The median progression-free survival (PFS) times were not reached during follow-up, 12.6 months, not reached during follow-up, and 4.8 months, respectively. The 1-year PFS rates were 84.1%, 55.0%, 69.8%, and 45.5%, respectively. The remaining 6 patients received other fluzoparib regimens. (4) Among the 224 patients in the prospective dataset, 205 had safety data recorded. Of these, 127 patients (62.0%, 127/205) experienced treatment-related adverse events, with common events including anemia (24.4%, 50/205), thrombocytopenia (21.0%, 43/205), and leukopenia (19.5%, 40/205). Among the 205 patients, 43 (21.0%, 43/205) experienced grade 3 or higher treatment-related adverse events, with common events including anemia (8.3%, 17/205) and thrombocytopenia (8.3%, 17/205).Conclusions:The effectiveness of fuzuloparib in clinical application is generally consistent with other drugs in the same class, with good safety. This study provids new clinical evidence for the treatment of ovarian cancer with fuzuloparib.

OBJECTIVE To explore the effect of oral cleaning with traditional Chinese medicine preparations on de-colonization of oropharyngeal bacteria and hospital-acquired pneumonia(HAP)in elderly patients undergoing non-inva-sive mechanical ventilation.METHODS A total of 520 elderly patients who were treated with non-invasive mechani-cal ventilation in Enze Hospital of Enze Medical Center(Group)from Jan.2022 to Dec.2024 were recruited as the research subjects and were randomly divided into the normal saline group and the traditional Chinese medicine(TCM)preparation group,with 260 cases in each group.The two groups were respectively treated with normal saline and TCM preparations for oral cleaning,twice a day in the morning and evening.The dental plaque index score,isolation rate of oropharyngeal pathogens,incidence of HAP and isolation rates of pathogens causing HAP were observed and compared between the two groups.RESULTS There were no significant differences in the dental plaque index score and the isolation rate of oropharyngeal pathogens between the two groups of patients before the first cleaning.However,the dental plaque index score and the isolation rate of oropharyngeal pathogens were low-er in the TCM preparation group than in the normal saline group after the first cleaning and the continuous clean-ing for 5 days(P＜0.05).The incidence of HAP of the TCM preparation group(3.63％)was lower than that of the normal saline group(8.91％)(x2=5.872,P=0.015).The isolation rate of gram-negative bacteria from lower respiratory tract secretions of the patients with HAP was lower in the TCM preparation group than in the normal saline group(P＜0.05);there were no significant differences in the isolation rates of gram-positive bacteria and fungi between the two groups.CONCLUSION As compared with the normal saline for routine oral cleaning of the elderly patients undergoing non-invasive mechanical ventilation,the TCM preparations may facilitate the decoloni-zation of oropharyngeal bacteria and remarkably reduce the incidence of HAP,which may provide a new idea for decolonization of oropharyngeal bacteria and reduction of incidence of HAP.

Objective:To explore the feasibility and efficacy for the dissection and ligation of the superior laryngeal artery in endoscopic surgery for hypopharyngeal cancer.Methods:Eight cadaveric heads were selected, and the laryngopharynxes were harvested. The positions of the superior laryngeal arteries entering the larynxes were dissected and observed under endoscopic vision, and their anatomical characteristics were summarized. Twenty-nine patients (all were male, aged 39-74 years old) with hypopharyngeal cancer who underwent transoral endoscopic surgery at the Department of Otorhinolaryngology Head and Neck Surgery of the Second Xiangya Hospital, Central South University from January 2018 to December 2019 were selected, and the patients were randomly divided into two groups by drawing lots, namely, the superior laryngeal artery was actively dissected and occluded during surgery in observation group ( n=15) or not in control group ( n=14). The differences in surgical time, bleeding volume, postoperative complications, and postoperative disease-free survival rate were compared between the two groups. Statistical analysis was conducted using SPSS 25.0 software. Results:The entry point of the superior laryngeal artery into the larynx was approximately at the level of the superior edge of the thyroid cartilage, and entered the larynx at the posterior one-third of the lateral wall of the pyriform fossa. The superior laryngeal artery might be determined through endoscopic exploration in all patients of observation group. The endoscopic surgery time [(40.00±7.56) minutes] and intraoperative bleeding volume [(24.00±8.28) ml] in the observation group were respectively less than those [(48.57±14.06) minutes and (42.86±15.41) ml] in the control group, and the differences were statistically significant ( t=-2.064, P=0.049; t=-4.064, P=0.001). There was no case with postoperative bleeding in the observation group, but with one case of postoperative bleeding in the control group. Total disease free survival rate was 86.2% and there was no significant difference in disease free survival rates between the two groups during a follow-up period of at least 36 months ( P=0.986). Conclusion:Dissection of the superior laryngeal artery during endoscopic surgery for hypopharyngeal cancer is feasible, and pre-management and occlusion of the superior laryngeal artery can effectively reduce intraoperative bleeding.

Objective:To explore the application of spiral tracheoplasty in the repair of large tracheal defects after the resection of trachea invaded by thyroid cancer.Methods:A retrospective analysis was performed on the clinical data of 11 patients, including 4 males and 7 females, aged from 36 to 67 years old, with large tracheal defects after tracheal resection due to thyroid papillary carcinoma invading the trachea in the Department of Otorhinolaryngology Head and Neck Surgery, Second Xiangya Hospital, Central South University from January 2019 to January 2022. The range of tracheal defects, time of tracheal reconstruction, postoperative complications and airway were recorded, and the patients were followed up for more than 24 months.Results:All patients underwent total thyroidectomy and tracheal resection and spiral reconstruction, and 2 of the cases underwent cricoid cartilage resection on the invaded side of cartilage. The tracheal defect accounted for 40%-60% of the circumference, and the lengths of the tracheal defects were 5.0 cm×7.5 cm and 6-9 tracheal rings, with 2 cases combined with partial defects of the cricoid cartilage. The reconstruction time was 30-60 min, with an average of 41.81 min. Among the 11 patients, 3 had recurrent laryngeal nerve paralysis, and 2 underwent tracheotomy. Four patients presented with hypocalcemia within one month after the operation. Followed up for 24-60 months, no tracheal stenosis occurred, the 2-year survival rate was 100%, the 2-year local control rate of the trachea was 100%, and the 2-year tumor-free survival rate was 81.8%.Conclusion:Spiral tracheoplasty is a safe and effective method that can reduce the tension at the tracheal anastomosis and expand the tracheal cavity, which can be used for tracheal reconstruction after extensive resection of trachea invaded by locally advanced thyroid cancer.

Patients with severe trauma require an extremely timely treatment and transfusion plays an irreplaceable role in the emergency treatment of such patients. An increasing number of evidence-based medicinal evidences and clinical practices suggest that patients with severe traumatic bleeding benefit from early transfusion of low-titer group O whole blood or hemostatic resuscitation with red blood cells, plasma and platelet of a balanced ratio. However, the current domestic mode of blood supply cannot fully meet the requirements of timely and effective blood transfusion for emergency treatment of patients with severe trauma in clinical practice. In order to solve the key problems in blood supply and blood transfusion strategies for emergency treatment of severe trauma, Branch of Clinical Transfusion Medicine of Chinese Medical Association, Group for Trauma Emergency Care and Multiple Injuries of Trauma Branch of Chinese Medical Association, Young Scholar Group of Disaster Medicine Branch of Chinese Medical Association organized domestic experts of blood transfusion medicine and trauma treatment to jointly formulate Chinese expert consensus on blood support mode and blood transfusion strategies for emergency treatment of severe trauma patients ( version 2024). Based on the evidence-based medical evidence and Delphi method of expert consultation and voting, 10 recommendations were put forward from two aspects of blood support mode and transfusion strategies, aiming to provide a reference for transfusion resuscitation in the emergency treatment of severe trauma and further improve the success rate of treatment of patients with severe trauma.

Objective:To explore the application of spiral tracheoplasty in the repair of large tracheal defects after the resection of trachea invaded by thyroid cancer.Methods:A retrospective analysis was performed on the clinical data of 11 patients, including 4 males and 7 females, aged from 36 to 67 years old, with large tracheal defects after tracheal resection due to thyroid papillary carcinoma invading the trachea in the Department of Otorhinolaryngology Head and Neck Surgery, Second Xiangya Hospital, Central South University from January 2019 to January 2022. The range of tracheal defects, time of tracheal reconstruction, postoperative complications and airway were recorded, and the patients were followed up for more than 24 months.Results:All patients underwent total thyroidectomy and tracheal resection and spiral reconstruction, and 2 of the cases underwent cricoid cartilage resection on the invaded side of cartilage. The tracheal defect accounted for 40%-60% of the circumference, and the lengths of the tracheal defects were 5.0 cm×7.5 cm and 6-9 tracheal rings, with 2 cases combined with partial defects of the cricoid cartilage. The reconstruction time was 30-60 min, with an average of 41.81 min. Among the 11 patients, 3 had recurrent laryngeal nerve paralysis, and 2 underwent tracheotomy. Four patients presented with hypocalcemia within one month after the operation. Followed up for 24-60 months, no tracheal stenosis occurred, the 2-year survival rate was 100%, the 2-year local control rate of the trachea was 100%, and the 2-year tumor-free survival rate was 81.8%.Conclusion:Spiral tracheoplasty is a safe and effective method that can reduce the tension at the tracheal anastomosis and expand the tracheal cavity, which can be used for tracheal reconstruction after extensive resection of trachea invaded by locally advanced thyroid cancer.

We conducted a prospective study to assess the non-inferiority of adjuvant chemotherapy alone versus adjuvant concurrent chemoradiotherapy (CCRT) as an alternative strategy for patients with early-stage (FIGO 2009 stage IB-IIA) cervical cancer having risk factors after surgery. The condition was assessed in terms of prognosis, adverse effects, and quality of life. This randomized trial involved nine centers across China. Eligible patients were randomized to receive adjuvant chemotherapy or CCRT after surgery. The primary end-point was progression-free survival (PFS). From December 2012 to December 2014, 337 patients were subjected to randomization. Final analysis included 329 patients, including 165 in the adjuvant chemotherapy group and 164 in the adjuvant CCRT group. The median follow-up was 72.1 months. The three-year PFS rates were both 91.9%, and the five-year OS was 90.6% versus 90.0% in adjuvant chemotherapy and CCRT groups, respectively. No significant differences were observed in the PFS or OS between groups. The adjusted HR for PFS was 0.854 (95% confidence interval 0.415-1.757; P = 0.667) favoring adjuvant chemotherapy, excluding the predefined non-inferiority boundary of 1.9. The chemotherapy group showed a tendency toward good quality of life. In comparison with post-operative adjuvant CCRT, adjuvant chemotherapy treatment showed non-inferior efficacy in patients with early-stage cervical cancer having pathological risk factors. Adjuvant chemotherapy alone is a favorable alternative post-operative treatment.
Female ; Humans ; Uterine Cervical Neoplasms/drug therapy* ; Prospective Studies ; Quality of Life ; Neoplasm Staging ; Chemoradiotherapy ; Chemotherapy, Adjuvant/adverse effects* ; Adjuvants, Immunologic ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use* ; Retrospective Studies